Document is current

Any future updates will be listed below

Correction : Long-term safety and clinical outcomes of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency: two-year results

Crossref DOI link: https://doi.org/10.1186/s13023-023-02647-z

Published Online: 2023-03-14

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark